Ian McLeod
2018
In 2018, Ian McLeod earned a total compensation of $952.4K as Interim Chief Financial Officer at ABIOMED.
Compensation breakdown
| Non-Equity Incentive Plan | $167,124 |
|---|---|
| Option Awards | $147,498 |
| Salary | $261,131 |
| Stock Awards | $376,628 |
| Total | $952,381 |
McLeod received $376.6K in stock awards, accounting for 40% of the total pay in 2018.
McLeod also received $167.1K in non-equity incentive plan, $147.5K in option awards and $261.1K in salary.
Rankings
In 2018, Ian McLeod's compensation ranked 9,438th out of 14,244 executives tracked by ExecPay. In other words, McLeod earned more than 33.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,438 out of 14,244 | 34th |
Division Manufacturing | 3,788 out of 5,765 | 34th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 503 out of 849 | 41st |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 307 out of 547 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 193 out of 348 | 45th |
Source: SEC filing on June 22, 2018.
McLeod's colleagues
We found five more compensation records of executives who worked with Ian McLeod at ABIOMED in 2018.
2018
Michael Minogue
ABIOMED
Chief Executive Officer
2018
David Weber
ABIOMED
Chief Operating Officer
2018
Michael Howley
ABIOMED
Vice President and General Manager, Global Sales
2018
William Bolt
ABIOMED
Senior Vice President, Global Quality, Regulatory and Clinical Operations
2018
Michael Tomsicek
ABIOMED